Marcus L. Sims, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 104 North Avenue H, Ozona, TX 76943 Phone: 325-392-3788 |
News Archive
Investigators at The Feinstein Institute for Medical Research have utilized a new image-based strategy to identify and measure placebo effects in randomized clinical trials for brain disorders. The findings are published in the August issue of The Journal of Clinical Investigation.
Even as herculean efforts are being made to extend the reach of vaccination against COVID-19 to all the regions of the world, there is a dire need for rapid and sensitive tests to assess the antibody response to the various vaccines used and to monitor antibody titers over time. A new preprint describes a new approach to this problem which could be applied to other molecules of interest as well, both in laboratories and at the point of care.
CitiusTech, a leading provider of healthcare technology solutions and services, has signed an agreement with 3M Health Information Systems to integrate the 3M(TM) Healthcare Data Dictionary with CitiusTech's BI-Clinical healthcare business intelligence framework. The agreement will enable BI-Clinical clients to leverage the robust capabilities of the 3M Healthcare Data Dictionary for enhanced terminology mapping across source systems.
Researchers at Worcester Polytechnic Institute are developing a sensor the size of a Band-Aid that will measure a baby's blood oxygen levels, a vital indication of the lungs' effectiveness and whether the baby's tissue is receiving adequate oxygen supply.
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that the peer-reviewed journal Molecular Therapy has published a paper entitled "Comparative Analysis of Immune Responses Induced by Vaccination With SIV Antigens by Recombinant Ad5 Vector or Plasmid DNA in Rhesus Macaques." The paper, co-authored by researchers from Merck, University of Pennsylvania School of Medicine, and Inovio Pharmaceuticals, notes that significant advances in the design, formulation, and delivery of DNA plasmid-based vaccines have dramatically increased their ability to induce antigen-specific immune responses.
› Verified 7 days ago